Amgen Enbrel (correction)
Executive Summary
Amgen did not run a statistical analysis on its clinical trial at six months (1"The Pink Sheet" May 17, 2004, p. 33). Enbrel (etanercept) received approval for psoriatic arthritis about a year before Biogen Idec Amevive (alefacept) gained approval for psoriasis...
You may also be interested in...
Amgen Enbrel 50 Mg Syringe Expected To Simplify Dosing For Psoriasis
Amgen expects to receive approval by year-end for an Enbrel 50 mg pre-filled syringe that could simplify dosing of the TNF inhibitor for treatment of plaque psoriasis and other indications
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.